相关实验视频

Updated: Jul 17, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

分子技术推动了皮肤T细胞淋巴瘤管理的尖端进展

Mitchell N Lefebvre^1,2, Nicholas Borcherding³, Ryan J Reis^1,4

¹University of Iowa Carver College of Medicine, Iowa City, IA, United States.

Frontiers in immunology

|September 1, 2023

概括

皮肤T细胞淋巴瘤 (CTCL) 的诊断是具有挑战性的. 像测序这样的先进分子技术提供了更好的早期检测和对CTCL病原学的理解,以获得更好的治疗.

科学领域:

皮肤病学皮肤病学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

皮肤T细胞淋巴瘤 (CTCL) 由于异质性和耐药性,存在诊断和治疗方面的挑战.
目前的诊断方法 (临床,组织病理学,免疫组织化学) 的灵敏度和特异性有限.

研究的目的:

审查CTCL诊断和治疗改进的分子技术的最新进展.
突出新型分子工具在应对CTCL临床挑战方面的潜力.

主要方法:

审查流细胞计,聚合酶连锁反应和高通量测序的最新进展.
专注于T细胞受体克隆类型和单细胞RNA测序在CTCL中的应用.

主要成果:

分子技术在提高CTCL诊断和治疗方面表现有前途.
在早期CTCL检测中有助于T细胞受体克隆类型.
单细胞RNA测序识别了CTCL病变的关键基因表达模式.

结论:

新型分子技术为改善CTCL的诊断准确性和治疗策略提供了显著的潜力.
这些进展为CTCL病原体提供了新的见解,为改善患者护理铺平了道路.

关键词:

有关RNA测序的RNA测序 TCR - T细胞受体 - T细胞受体皮肤T细胞淋巴瘤流动细胞计量是流动细胞计量的方法.高吞吐量测序的测序

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...